Hjem › Nyrekreft (nyrecellekarcinom) › Iowa
Kliniske studier for Nyrekreft (nyrecellekarcinom) i Iowa
9 studier for Nyrekreft (nyrecellekarcinom) søker deltakere på steder i Iowa.
Byer i Iowa
- Cedar Rapids7 studier
- Ames5 studier
- Marshalltown4 studier
- Fort Dodge4 studier
- Des Moines3 studier
- Davenport3 studier
Offisiell studietekst (engelsk)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
- UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
- og 12 flere
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
- UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
- og 10 flere
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT03866382A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
- University Of Iowa Hospitals And Clinics, Iowa City
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07293351Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
- UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
- og 5 flere
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT05327686Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
- University of Iowa Healthcare Cancer Services Quad Cities, Bettendorf
- og 5 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT06661720A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- University of Iowa, Iowa City
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT04895709Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 11. jun. 2026 · NCT07383441KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- University of Iowa Hospitals & Clinics, Iowa City
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 8. jun. 2026 · NCT06026410Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
- McFarland Clinic - Boone, Boone
- og 3 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2025 · NCT04510597Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.